Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes

被引：0

作者：

Bourlon, Christianne ^{[1
]}

Roddie, Claire ^{[2
,3
]}

Menne, Tobias ^{[4
]}

Norman, Jane ^{[5
]}

O'Reilly, Maeve ^{[2
]}

Gibb, Adam ^{[6
]}

Besley, Caroline ^{[7
]}

Chaganti, Sridhar ^{[8
]}

Arias, Carlos Gonzalez ^{[9
]}

Jones, Ceri ^{[10
]}

Dikair, Abdalla ^{[11
]}

Allen, Sharon ^{[12
]}

Seymour, Frances ^{[13
]}

Osborne, Wendy ^{[4
]}

Mathew, Amrith ^{[8
]}

Townsend, William ^{[2
]}

Patten, Piers E. M. ^{[1
,14
]}

Thoulouli, Eleni ^{[5
]}

Abdulgawad, Ahmed ^{[15
]}

Lugthart, Sanne ^{[7
]}

Sanderson, Robin ^{[1
]}

Kirkwood, Amy A. ^{[16
]}

Kuhnl, Andrea ^{[1
]}

机构：

[1] Kings Coll Hosp London, Dept Hematol, London, England

[2] Univ Coll London Hosp, Dept Hematol, London, England

[3] UCL, UCL Canc Inst, London, England

[4] Newcastle Univ, Freeman Hosp, Dept Hematol, Newcastle, England

[5] Manchester Royal Infirm, Dept Hematol, Manchester, England

[6] Christie Hosp, Dept Med Oncol, Manchester, England

[7] Univ Hosp Bristol & Weston, Dept Hematol, Bristol, England

[8] Queen Elizabeth Hosp, Dept Hematol, Birmingham, England

[9] Royal Marsden Hosp, Dept Hematol, London, England

[10] Univ Hosp Wales, Dept Hematol, Cardiff, England

[11] Queen Elizabeth Hosp, Dept Hematol, Glasgow, Scotland

[12] Cambridge Univ Hosp, Dept Hematol, Cambridge, England

[13] Leeds Teaching Hosp, Dept Hematol, Leeds, England

[14] Kings Coll London, Comprehens Canc Ctr, London, England

[15] Christie Hosp, Dept Hematol, Manchester, England

[16] UCL, UCL Canc Inst, CR UK & UCL Canc Trials Ctr, London, England

来源：

HAEMATOLOGICA | 2024年 / 109卷 / 08期

关键词：

D O I：

10.3324/haematol.2024.285010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2716 / 2720

页数：5

共 50 条

[1] Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy
Iacoboni, Gloria
Iraola-Truchuelo, Josu
O'Reilly, Maeve
Navarro, Victor
Menne, Tobias
Kwon, Mi
Martin-Lopez, Ana africa
Chaganti, Sridhar
Delgado, Javier
Roddie, Claire
Perez, Ariadna
Norman, Jane
Guerreiro, Manuel
Gibb, Adam
Caballero, Ana Carolina
Besley, Caroline
Martinez-Cibrian, Nuria
Mussetti, Alberto
Sanderson, Robin
Luzardo, Hugo
Iyengar, Sunil
Sanchez, Jose Maria
Jones, Ceri
Sancho, Juan-Manuel
Barba, Pere
Latif, Anne-Louise
Lopez-Corral, Lucia
Hernani, Rafael
Reguera, Juan Luis
Sureda, Anna
Garcia-Sancho, Alejandro Martin
Bastos, Mariana
Abrisqueta, Pau
Kuhnl, Andrea
HEMASPHERE, 2024, 8 (05):
[2] Chimeric Antigen Receptor T-Cell Therapy and Imaging Applications for Large B-Cell Lymphoma
Mulholland, Nicola
Chandra, Julie
Sanderson, Robin
Kuhnl, Andrea
RADIOLOGY, 2023, 307 (05)
[3] Characterization of Infections After Chimeric Antigen Receptor T-Cell Therapy in Patients With Large B-Cell Lymphoma
Pernas, Berta
Iacoboni, Gloria
Los-Arcos, Ibai
Catala, Eva
Carpio, Cecilia
Barba, Pere
Ruiz-Camps, Isabel
BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 196 - 196
[4] Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma
Hamilton, Mark P.
Miklos, David B.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1053 - 1075
[5] Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma
Zhou, Wenyujing
Chen, Weihong
Wan, Xiaochun
Luo, Changru
Du, Xin
Li, Xiaoqing
Chen, Qian
Gao, Ruiwen
Zhang, Xiaohan
Xie, Mei
Wang, Mingjun
FRONTIERS IN GENETICS, 2022, 12
[6] Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma
Nath, Karthik
Tomas, Ana Alarcon
Flynn, Jessica
Fein, Joshua A.
Alperovich, Anna
Anagnostou, Theodora
Batlevi, Connie Lee
Dahi, Parastoo B.
Fingrut, Warren B.
Giralt, Sergio A.
Lin, Richard J.
Palomba, M. Lia
Peled, Jonathan U.
Salles, Gilles
Sauter, Craig S.
Scordo, Michael
Fraint, Ellen
Feuer, Elise
Shah, Nishi
Slingerland, John B.
Devlin, Sean
Shah, Gunjan L.
Gupta, Gaurav
Perales, Miguel-Angel
Shouval, Roni
TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (11): : 751.e1 - 751.e7
[7] PET Radiomic Features Are Predictive of Outcomes after Chimeric Antigen Receptor T-Cell Therapy in Patients with Large B-Cell Lymphoma
Barba, Pere
Ligero, Marta
Carpio, Cecilia
Balaguer, Maria
Navarro Garces, Victor
Bobillo, Sabela
Beas, Francisco
Abrisqueta, Pau
Sala, Roser
Bosch, Francesc
Iacoboni, Gloria
Simo, Marc
Perez-Lopez, Raquel
BLOOD, 2022, 140 : 3783 - 3784
[8] Bilateral Cytomegalovirus Retinitis After Chimeric Antigen Receptor T-cell Therapy for B-cell Lymphoma
Meller, Leo
Jagadeesh, Vasan
Wilson, Katherine
Oca, Michael C.
Sestak, Timothy
Scott, Nathan
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
[9] Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell Lymphoma
Hubbeling, Harper
Leithner, Doris
Silverman, Emily A.
Flynn, Jessica
Devlin, Sean
Shah, Gunjan
Fregonese, Beatrice
Wills, Beatriz
Bedmutha, Akshay
Tomas, Ana Alarcon
Parascondola, Allison
Saldia, Amethyst
Landego, Ivan
Hajj, Carla
Boardman, Alexander P.
Dahi, Parastoo B.
Ghosh, Arnab
Giralt, Sergio
Lin, Richard J.
Park, Jae
Scordo, Michael
Salles, Gilles
Yahalom, Joachim
Palomba, Maria L.
Schoeder, Heiko
Perales, Miguel-Angel
Shouval, Roni
Imber, Brandon S.
CLINICAL CANCER RESEARCH, 2024, 30 (22) : 5083 - 5093
[10] Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma
Lutfi, Forat
Holtzman, Noa
Siglin, Jonathan
Bukhari, Ali
Mustafa Ali, Moaath
Kim, Dong
Sanchez-Petitto, Gabriela
Gottlieb, David
Ruehle, Kathleen
Hutnick, Elizabeth
Gahres, Natalie
Hankey, Kim
Lee, Seung
Kocoglu, Mehmet
Yared, Jean
Hardy, Nancy
Rapoport, Aaron
Dahiya, Saurabh
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (01) : 212 - 216

← 1 2 3 4 5 →